S. Cedrés
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
-
- Occupational and environmental lung diseases
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in
-
- Occupational and environmental lung diseases 27
- Lung Cancer Treatments and Mutations 26
- Pleural and Pulmonary Diseases 9
- Lung Cancer Diagnosis and Treatment 7
- Oncology 32
- Cancer Immunotherapy and Biomarkers 16
- Lung Cancer Research Studies 6
- Co-authors
- Enriqueta Felip (53 shared papers)Pablo Martínez (17 shared papers)Alejandro Navarro (33 shared papers)Alex Martínez‐Martí (27 shared papers)Davis Y. Torrejon (5 shared papers)Joachim G.J.V. Aerts (8 shared papers)Núria Pardo (21 shared papers)Esther Zamora (4 shared papers)
In The Last Decade
S. Cedrés
76 papers receiving 2.3k citations
S. Cedrés's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 1.0k
- Biotechnology 149
- Cancer Research 186
- Immunology 251
Countries citing papers authored by S. Cedrés
This map shows the geographic impact of S. Cedrés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Cedrés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Cedrés more than expected).
Fields of papers citing papers by S. Cedrés
This network shows the impact of papers produced by S. Cedrés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Cedrés. The network helps show where S. Cedrés may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Cedrés, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial Hit paper breakdown → | 2017 | 323 |
| 2 | 2017 | 286 | |
| 3 | 2012 | 225 | |
| 4 | 2011 | 168 | |
| 5 | 2015 | 157 | |
| 6 | 2019 | 117 | |
| 7 | 2019 | 93 | |
| 8 | 2007 | 79 | |
| 9 | 2008 | 70 | |
| 10 | 2022 | 61 | |
| 11 | 2012 | 57 | |
| 12 | 2017 | 57 | |
| 13 | 2013 | 56 | |
| 14 | 2010 | 38 | |
| 15 | 2016 | 35 | |
| 16 | 2016 | 32 | |
| 17 | 2020 | 27 | |
| 18 | 2017 | 25 | |
| 19 | 2023 | 22 | |
| 20 | 2023 | 21 |
About S. Cedrés
S. Cedrés is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biotechnology, Cancer Research and Molecular Biology, having authored 80 papers that have together received 2.3k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (27 papers), Lung Cancer Treatments and Mutations (26 papers), Cancer Immunotherapy and Biomarkers (16 papers), Pleural and Pulmonary Diseases (9 papers), Cancer Research and Treatments (9 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (1.0k citations), Biotechnology (149 citations), Cancer Research (186 citations) and Immunology (251 citations). S. Cedrés has collaborated with scholars based in Spain, France and Belgium. Frequent co-authors include Enriqueta Felip, Pablo Martínez, Alejandro Navarro, Alex Martínez‐Martí, Davis Y. Torrejon, Joachim G.J.V. Aerts, Núria Pardo, Esther Zamora, Federica Grosso and Anna K. Nowak. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Lung Cancer, Clinical & Translational Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.